TickerFactsScreenerDevelopers

Semnur Pharmaceuticals, Inc. (SMNR) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2022: $819.7K2023: $204.5K2024: $12.0K2025: $20.0K$20.0K
2022Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$20.0K+66.7%
2024$12.0K-94.1%
2023$204.5K-75.1%
2022$819.7K—